[PRELIMINARY CLINICO-EXPERIMENTAL EXPERIENCES WITH BISOLVON, A MUCOLYTIC AGENT].
D000336:Aerosols; D001249:Asthma; D001964:Bromhexine; D001991:Bronchitis; D004247:DNA; D004269:DNA, Bacterial; D004358:Drug Therapy; D005100:Expectorants; D006025:Glycosaminoglycans; D006651:Histocytochemistry; D006801:Humans; D009088:Mucoproteins; D012138:Respiratory Therapy; D013183:Sputum
D000336:Aerosols; D004269:DNA, Bacterial; D005100:Expectorants; D006025:Glycosaminoglycans; D009088:Mucoproteins; D004247:DNA; D001964:Bromhexine
AEROSOLS; ASTHMA; BRONCHITIS; DNA, BACTERIAL; DRUG THERAPY; EXPECTORANTS; HISTOCYTOCHEMISTRY; INHALATION THERAPY; MUCOPOLYSACCHARIDES; MUCOPROTEINS; SPUTUM
ERSTE KLINISCH-EXPERIMENTELLE ERFAHRUNGEN MIT DEM MUCOLYTICUM BISOLVON.